Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1004-1010, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow
Right arrow Supplemental Table
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wasmuth, J.-C.
Right arrow Articles by Spengler, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wasmuth, J.-C.
Right arrow Articles by Spengler, U.
Related Collections
Right arrow Clinical Immunology
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Hemostasis and Thrombosis
Right arrow Hematology
(Clinical Chemistry. 2002;48:1004-1010.)
© 2002 American Association for Clinical Chemistry, Inc.

Phospholipid Autoantibodies and the Antiphospholipid Antibody Syndrome: Diagnostic Accuracy of 23 Methods Studied by Variation in ROC Curves with Number of Clinical Manifestations

Jan-Christian Wasmutha1, Desamparados Oliver y Miñarro1, Angela Homrighausen1, Ludger Leifeld1, Jürgen K. Rockstroh1, Tilman Sauerbruch1 and Ulrich Spengler1

1 Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany

aAuthor for correspondence. Fax 49-228287-5034; e-mail j-c.wasmuth{at}uni-bonn.de.

Background: We analyzed the diagnostic accuracies for the diagnosis of antiphospholipid syndrome (APS) of 23 antiphospholipid antibody (APL-Ab) assays targeted at different antigen preparations and immunoglobulin isotypes.

Methods: In 144 patients with suspected APS, anti-cardiolipin (aCL) and anti-ß2-glycoprotein I (aß2GPI) antibodies were measured with 23 different ELISAs from three manufacturers. Data were analyzed by ROC curves. In the absence of an accepted criterion standard, the endpoint "diagnosis of APS" was varied according to the number (two through five) of signs and symptoms of APS.

Results: Although the presence of lupus anticoagulant was associated significantly with APL-Ab in 10 of 23 assays (P = 0.01–10-4) and recurrent arterial or venous occlusions were significantly associated with APL-Ab of IgM isotype in 5 of 6 assays (P = 0.02–10-4), sensitivity for detection of APS did not exceed 67%. With the exception of IgA APL-Ab, the diagnostic accuracy of the assays improved when the diagnosis of APS was based on an increasing number of simultaneous features of APS. For most methods, areas under the ROC curves were >0.8 irrespective of the method’s subclass specificity and antigen preparation (aCL or aß2GPI), if the clinical diagnosis of APS was based on four or more signs and symptoms of APS.

Conclusion: Despite considerable heterogeneity in the individual test results, a single test of IgG or IgM isotype targeted at either aCL or aß2GPI antibodies has excellent diagnostic accuracy when the criterion for diagnosis requires four or more typical manifestations of APS.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J.-C. Wasmuth, B. Grun, B. Terjung, A. Homrighausen, and U. Spengler
ROC Analysis Comparison of Three Assays for the Detection of Antibodies against Double-Stranded DNA in Serum for the Diagnosis of Systemic Lupus Erythematosus
Clin. Chem., November 1, 2004; 50(11): 2169 - 2171.
[Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker
Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
Clinical and Applied Thrombosis/Hemostasis, April 1, 2004; 10(2): 89 - 126.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.